Transdermal delivery of 5-fluorouracil (5-FU) by 1-alkylcarbonyl-5-FU prodrugs

被引:27
|
作者
Beall, HD [1 ]
Sloan, KB [1 ]
机构
[1] UNIV FLORIDA,DEPT MED CHEM,GAINESVILLE,FL 32610
关键词
1-alkylcarbonyl-5-FU; diffusion cell; water and lipid solubility; partition coefficients; flux; skin accumulation; solubility parameters;
D O I
10.1016/0378-5173(95)04327-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The members of a series of 1-alkylcarbonyl-5-FU prodrug derivatives have been characterized and evaluated for their abilities to deliver 5-FU into and through skin. There was no correlation of lipid solubility or partition coefficient with relative abilities of the members of the 1-alkylcarbonyl series to deliver 5-FU through skin. However, there was a correlation with water solubility within the series. Although their lipid solubilities and partition coefficient values were greater than those of the 1-alkyloxycarbonyl series, only 1-acetyl-5-FU was more soluble in water, and only 1-acetyl-5-FU delivered more total 5-FU species through the skin than the corresponding member of the 1-alkyloxycarbonyl series. On the other hand, the 1-alkylcarbonyl series was more effective at enhancing the ratio of dermal to transdermal delivery (D/T delivery ratio) than the 1-alkyloxycarbonyl series, presumably because of the rapid hydrolysis of the members of the former series once contact with the aqueous domains of the epidermis had been made. Thus, the hypothesis that enhanced D/T delivery ratio requires rapid hydrolysis of the prodrug after it partitions into the skin is supported. Although the prodrugs hydrolyzed rapidly in water, they were stable in isopropyl myristate (IPM) during their application in IPM to highly hydrated skin. There was also a good correlation of calculated solubility parameters for the prodrugs with their permeability coefficients.
引用
收藏
页码:203 / 210
页数:8
相关论文
共 50 条
  • [41] SYNERGISTIC LETHAL EFFECTS OF ENDOTOXIN AND 5-FLUOROURACIL (5-FU) IN MOUSE
    NOVAK, D
    DRUMMOND, D
    MUNSON, AE
    [J]. JOURNAL OF THE RETICULOENDOTHELIAL SOCIETY, 1973, 13 (04): : 354 - 354
  • [42] EFFECTS OF 5-FLUOROURACIL (5-FU) OINTMENT IN TREATMENT OF NEOPLASTIC DERMATOSES
    KLEIN, E
    STOLL, HL
    MILLER, E
    MILGROM, H
    HELM, F
    BURGESS, G
    [J]. DERMATOLOGICA, 1970, 140 : 21 - +
  • [43] 5-FLUOROURACIL (5-FU) IN PRIMARY TRABECULECTOMY - A PROSPECTIVE, RANDOMIZED STUDY
    GOLDENFELD, M
    WONG, P
    RUDERMAN, J
    ROSENBERG, L
    KRUPIN, T
    GEISER, D
    LIEBMANN, J
    RITCH, R
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1993, 34 (04) : 815 - 815
  • [44] TREATMENT OF KERATOACANTHOMAS BY LOCAL APPLICATIONS OF 5-FLUOROURACIL (5-FU) OINTMENT
    GRUPPER, C
    [J]. DERMATOLOGICA, 1970, 140 : 127 - &
  • [45] ORAL 5-FLUOROURACIL (5-FU) AS AN ADJUVANT TO SURGERY IN CARCINOMA OF COLON
    HARVEY, H
    BADDER, E
    DEMUTH, W
    NAHRWOLD, D
    PATTERSON, L
    RICCI, J
    SHAVER, W
    WHITE, D
    LIPTON, A
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1977, 18 (MAR): : 314 - 314
  • [46] NEEDLING WITH 5-FLUOROURACIL (5-FU) AND BETAMETHASONE IN FAILING FILTERING BLEBS
    FERRARI, E
    LANZETTA, P
    VIRGIL, G
    MENCHINI, U
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1995, 36 (04) : S85 - S85
  • [47] TREATMENT OF BASAL CELL CARCINOMA WITH 5-FLUOROURACIL (5-FU) OINTMENT
    REYMANN, F
    [J]. DERMATOLOGICA, 1970, 140 : 34 - &
  • [48] 5-FLUOROURACIL (5-FU) OINTMENT IN TREATMENT OF SKIN TUMOURS AND KERATOSES
    ALMEIDAG.JC
    NORONHA, TD
    [J]. DERMATOLOGICA, 1970, 140 : 97 - &
  • [49] Continuous infusion of 5-fluorouracil (5-FU) in neuroendocrine tumours (NET)
    Ducreux, M
    Baudin, E
    Thabut, D
    Rougier, P
    Tigaud, JM
    Elias, D
    Boige, V
    Schlumberger, M
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S213 - S213
  • [50] CAN NMR CONTRIBUTE TO THE RADIOPHARMACOKINETICS OF 5-FLUOROURACIL (5-FU) IN MAN
    WOLF, W
    GRIFFITHS, JR
    SILVER, M
    BRUCKNER, H
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1986, 27 (05) : 737 - 737